Cure SMA Awards $150,000 Grant to Veronica Pessino, PhD, Salk Institute for Biological Sciences

Audrey Lewis founded Families of SMA, now Cure SMA, 34 years ago. Audrey recognized early on the importance of attracting new and talented researchers to SMA, with the hope that they would commit their careers to developing a treatment and cure for SMA. Cure SMA honors Audrey’s legacy with the Audrey Lewis Young Investigator Award, […]

Cure SMA Awards $150,000 Grant to Veronica Pessino, PhD, Salk Institute for Biological Sciences Read More »

Community Spotlight: Amber Bosselman

Amber Bosselman is your typical 22-year-old college senior. She is currently studying psychology in Idaho and planning to get her master’s degree in industrial psychology. Amber’s life is similar to other students, except she was born with a rare disease called spinal muscular atrophy (SMA). SMA is a disease that robs people of strength by

Community Spotlight: Amber Bosselman Read More »

Cure SMA Awards $150,000 Grant to Laxman Gangwani, PhD, Texas Tech University

Cure SMA has awarded a $150,000 research grant to Laxman Gangwani, PhD, at the Texas Tech University Health Sciences Center, for his project entitled, “Function of Senataxin as a Protective Modifier of Spinal Muscular Atrophy”. Dr. Gangwani and his team will study how the expression of the Senataxin protein may serve as a protective genetic

Cure SMA Awards $150,000 Grant to Laxman Gangwani, PhD, Texas Tech University Read More »

Register for Cure SMA’s Advocacy 101 Webinar: Learn How to Make a Difference

On Wednesday, February 20th at 12pm CST (10am PST/11am MST/1pm EST) Cure SMA’s Policy and Advocacy team will hold a webinar to update the SMA community on the current advocacy priorities. Advocacy can be confusing and intimidating, but it is critical to making sure that policymakers hear the voice of the SMA Community. Topics covered

Register for Cure SMA’s Advocacy 101 Webinar: Learn How to Make a Difference Read More »

Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients with SMA

Cytokinetics, Incorporated (CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) is an acceptable primary efficacy endpoint for a potential registration program for reldesemtiv in patients with spinal muscular atrophy (SMA) who have maintained ambulatory function. The FDA also recommended adding

Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients with SMA Read More »

Cure SMA is Thrilled to Launch Its New and Refreshed Endurance Program: Team Cure SMA

Start 2019 Strong by becoming a Team Cure SMA runner, registering a team or donating to a race today.  Team Cure SMA is an endurance program designed to connect runners and cyclists with Cure SMA. Cure SMA, is a 501(c)3 nonprofit organization dedicated to the treatment and cure of spinal muscular atrophy (SMA). SMA is a

Cure SMA is Thrilled to Launch Its New and Refreshed Endurance Program: Team Cure SMA Read More »

Be A Part of Cure SMA’s Valentine’s Day Advocacy Campaign and Support the Newborn Screening Saves Lives Reauthorization Act

With Valentine’s Day rapidly approaching, we are showing our love for the Newborn Screening Saves Lives Reauthorization Act! Take action to support this very important bill by sending a Valentine’s Day card to your Members of Congress. Valentine’s Day Advocacy Campaign Be an advocate for newborn screening! It is time to get artistically creative and

Be A Part of Cure SMA’s Valentine’s Day Advocacy Campaign and Support the Newborn Screening Saves Lives Reauthorization Act Read More »

Scroll to Top